Prasco, LLC
Mason, OH
- UEI
- SCLNYKUMMSN5
- CAGE
- 6TJY6
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 6125 Commerce Ct, Mason, OH 45040, USA
- Website
- prasco.com
- Founded
- 2002
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $178,712 |
| FY2025 | $216,785 |
| FY2024 | $325,609 |
| FY2023 | $145,819 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Logistics Agency | $178,712 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Other medical | Medical Supply Chain (DLA) | $177,992 | |
| Nitroglycerin 400 MCG spray 12GM | Medical Supply Chain (DLA) | $721 | |
| Atovaquone-proguanil 250-100 100S | Medical Supply Chain (DLA) | $2,844 | |
| Atovaquone-proguanil 250-100 100S | Medical Supply Chain (DLA) | $4,550 | |
| Atovaquone-proguanil 250-100 100S | Medical Supply Chain (DLA) | $3,981 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Chartwell RX LLC | Congers, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Amneal Pharmaceuticals Of New York, LLC | Medford, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Pfizer Inc. | New York, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Corporate Office | Conshohocken, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Avkare LLC | Pulaski, TN | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Prasco, LLC, a for-profit pharmaceutical manufacturer and distributor headquartered in Mason, Ohio, operates as a prime contractor supplying pharmaceutical and medical products to federal agencies through full-and-open competition, with no SBA set-aside designations across its recent prime award footprint. The company has been registered as a federal contractor since October 2012 and competes across two principal vehicle types: a single-award Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical valued at $31.7 billion through June 2034, and the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
Prasco's capability portfolio centers on antimalarial medications (particularly atovaquone-proguanil combinations), topical pharmaceuticals (calcipotriene cream), dental products (sodium fluoride gel), and general medical supplies. Representative prime work includes a $31.7 billion single-award IDC with Medical Supply Chain (DLA) awarded June 2024, under which Prasco has executed five delivery orders between June 2024 and September 2025 for antimalarial tablets and other medical supplies ranging from $2,843.60 to $205,410.76 per order; six delivery orders through the GSA Pharmaceuticals and Drugs schedule to the CDC for atovaquone-proguanil tablets (ranging from $24,647 to $26,069 per order, 2022–2024); and two small-business-set-aside purchase orders from the Department of Veterans Affairs Veterans Integrated Service Network 15 for calcipotriene topical cream ($170,071.20, March 2024) and sodium fluoride dental gel ($71,877.60, September 2023).
Customer concentration is extreme. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 anchors 84% of combined potential value ($459.4 million from 2 awards), while the DLA accounts for $50.3 million across 8 awards (9% of potential value). The CDC and other VA service networks represent the remaining 7%. Award volume has remained flat over the past five years (1–4 awards annually from 2022–2025), with a single award in early 2026. Prasco holds positions on the DLA single-award IDC (6 task orders, $349 thousand combined value) and the GSA Pharmaceuticals and Drugs schedule (6 task orders, $2.4 million combined value). The combined potential value across all nineteen awards totals $544.2 million, though only $1 million has been obligated to date, indicating the awards are structured as indefinite-quantity vehicles with delivery orders placed as needed rather than firm commitments. Prasco does not operate as a subcontractor on federal awards and competes exclusively as a prime contractor across pharmaceutical preparation manufacturing (NAICS 325412) and medicinal and botanical manufacturing (NAICS 325411) categories.
Quick answers
Is Prasco, LLC registered in SAM.gov?
Yes. Prasco, LLC's SAM.gov registration is active through July 23, 2027.
Which contract vehicles does Prasco, LLC hold?
Prasco, LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Prasco, LLC received in federal contracts?
Federal contracts obligated $216,785 to Prasco, LLC in fiscal year 2025 and $866,925 in fiscal years 2023 through 2027.
How does Prasco, LLC rank among federal contractors?
Prasco, LLC ranked #25 in NAICS 325411 in FY2025.
What is Prasco, LLC's most recent federal award?
Prasco, LLC's most recent federal contract award is Other medical (SPE2D026F0204), from Medical Supply Chain (DLA), on May 26, 2026.
On GovTribe
See Prasco, LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors